Research study Program year 2023 Source: CMS Open Payments

Phase P3 Pediatric Study (EM)

Research payments

$997,083

154 payments

Through program year 2023, $997,083 in research payments was reported against Phase P3 Pediatric Study (EM), across 154 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$537,848	35
2022	Research	$162,698	36
2019	Research	$296,537	83

Breakdown

Who paid Research payments · program years 2019–2023

Amgen Inc. $997,083 154 payments

Who received the money Research payments · program years 2019–2023

Children's Specialty Group Pllc Organisation paid for research $91,185 2 payments
Childrens Mercy Hospital Teaching hospital · MO $86,894 10 payments
Mercy Research Organisation paid for research $75,181 4 payments
Elligo Health Research INC Organisation paid for research $59,509 2 payments
Childrens National Health System Organisation paid for research $55,343 4 payments
Vaught Neurological Services Organisation paid for research $48,387 2 payments
Michigan Headache And Neurological Organisation paid for research $36,081 4 payments
Preferred Primary Care Physicians Organisation paid for research $35,464 3 payments
State Of Maryland Dba University Of Maryland Baltimore Organisation paid for research $31,695 3 payments
Childrens Hospital Colorado Teaching hospital · CO $30,693 5 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.